Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT01583153




Registration number
NCT01583153
Ethics application status
Date submitted
19/04/2012
Date registered
23/04/2012
Date last updated
14/04/2016

Titles & IDs
Public title
The HIHO Study: Hospital Inpatient vs Home Rehabilitation After Total Knee Replacement
Scientific title
Randomised Controlled Trial Comparing Hospital Inpatient vs Home Rehabilitation After Total Knee
Secondary ID [1] 0 0
HIHO-1042554
Universal Trial Number (UTN)
Trial acronym
HIHO
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Osteoarthritis 0 0
Condition category
Condition code
Musculoskeletal 0 0 0 0
Osteoarthritis

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Other interventions - Hospital Inpatient Rehabilitation
Other interventions - Hybrid Home Programme (HO)

Active comparator: Hospital Inpatient Rehabilitation (HI) -

Active comparator: Hybrid Home Programme (HO) -


Other interventions: Hospital Inpatient Rehabilitation
Those allocated to HI will be admitted to the adjacent rehabilitation hospital, Braeside Rehabilitation Hospital, for 10 days. As per the private sector, HI participants will receive twice-daily supervised physiotherapy comprising 1-1.5 hr class-based exercises and 1-1.5 hr one-to-one therapy. Prior to discharge, participants will be familiarised with the home programme as described in second arm. All participants will be required to complete a diary detailing programme adherence, healthcare utilisation, and social costs relating to carer-burden. Participants will attend the group-based sessions as per HO below for monitoring and progression of programme. An additional FIM outcome measure will be taken for this arm on admission and discharge from the inpatient rehab unit.

Other interventions: Hybrid Home Programme (HO)
The HO will be based on what is standard care in the local health district and guidelines for exercise in the elderly and those with osteoarthritis. Approximately 2 weeks post-surgery, participants allocated to the HO will attend 1 group-based exercise session in the Physiotherapy Department (Fairfield Hospital) where the home programme will be rehearsed and exercises individualised as required due to co-morbidities. The programme comprises general aerobic components as well as general functional and muscle-specific exercises focused on restoring knee mobility, lower limb strength, and normal neuromuscular co-ordination and gait patterns. Participants will be able to return for 2-3 sessions over the 6-week period.
Intervention code [1] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Walking distance at 6 months post surgery, measured using the Six-Minute Walk Test (6MWT)
Timepoint [1] 0 0
Pre surgery; 10 weeks, six months and twelve months after surgery.
Secondary outcome [1] 0 0
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Timepoint [1] 0 0
Pre surgery; 10 weeks, six months and twelve months after surgery.
Secondary outcome [2] 0 0
Knee range of motion
Timepoint [2] 0 0
Pre surgery; 10 weeks, six months and twelve months after surgery.
Secondary outcome [3] 0 0
EQ5D
Timepoint [3] 0 0
Pre surgery; 10 weeks, six months and twelve months after surgery.
Secondary outcome [4] 0 0
Cost of surgery
Timepoint [4] 0 0
Pre surgery; 10 weeks, six months and twelve months after surgery.
Secondary outcome [5] 0 0
Patient preference for therapy
Timepoint [5] 0 0
After consenting to participation and prior to randomisation
Secondary outcome [6] 0 0
15 metre walk test
Timepoint [6] 0 0
Pre surgery; 10 weeks, six months and twelve months after surgery.

Eligibility
Key inclusion criteria
* Consecutive patients presenting for elective, primary, unilateral TKR at the Whitlam Joint Replacement Centre (Fairfield Hospital) will be screened for eligibility at the pre-admission clinic by the study Project Manager (PM).
* primary diagnosis of OA
Minimum age
No limit
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* predisposition for requiring prolonged inpatient supervision (eg requiring assistance with at least one personal activity of daily living or lack of social support)
* inability to comprehend the study protocol.
* catastrophic complication arising post-surgery which precludes rehabilitation commencing within 2-3 weeks of surgery

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
Intervention assignment
Parallel
Other design features
Phase
NA
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/06/2012
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/12/2015
Sample size
Target
Accrual to date
Final
165
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 0 0
Braeside Hospital - Sydney
Recruitment hospital [2] 0 0
Fairfield Hospital - Sydney
Recruitment hospital [3] 0 0
Sutherland Hospital - Sydney
Recruitment postcode(s) [1] 0 0
2176 - Sydney
Recruitment postcode(s) [2] 0 0
2229 - Sydney

Funding & Sponsors
Primary sponsor type
Other
Name
Mark Buhagiar
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
HammondCare
Address [1] 0 0
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Justine M Naylor, PhD BAppSc(Phty)
Address 0 0
SWSLHD
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results not provided in https://clinicaltrials.gov/study/NCT01583153